Regenxbio Inc (NASDAQ:RGNX)
| 19.96 Delayed Data As of 3:59pm ET |  +0.27 / +1.37%Today’s Change | 18.69 Today|||52-Week Range 35.73 | -11.99% Year-to-Date |
Latest RGNX News | Press Releases
No recent news for Regenxbio Inc.
Today’s Trading
| Previous close | 19.69 |
| Today’s open | 19.90 |
| Day’s range | 19.57 - 20.38 |
| Volume | 9,064 |
| Average volume (3 months) | 390,084 |
| Market cap | $874.9M |
Data as of 3:59pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -315.65% |
| Earnings growth (this year) | +34.15% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -76.03% |
| P/E ratio | NM |
| Price/Sales | 8.68 |
| Price/Book | 1.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QUREUniqure NV | +1.30 | +6.95% |
| IMGNImmunoGen Inc | +0.06 | +1.63% |
| MRUSMerus NV | +0.10 | +0.52% |
| TWSTTwist Bioscience Cor... | +0.14 | +0.88% |
Data as of 3:59pm ET, 03/23/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$1.42 |
| Annual revenue (last year) | $112.7M |
| Annual profit (last year) | -$280.3M |
| Net profit margin | -248.68% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
